
Drugs (psychoactive) - World Health Organization (WHO)
2024年6月25日 · About 296 million people aged 15-64 had used psychoactive drugs in 2021 and about 39.5 million people are estimated to be affected by drug use disorders (harmful pattern of drug use or drug dependence). It is estimated that about 0.6 million death annually are attributable to drug use with about 420 000 male and 160 000 female deaths.
WHO Drug Information - World Health Organization (WHO)
WHO Drug Information provides an overview of topics relating to drug development and regulation that are of current relevance and importance, and includes the lists of proposed and recommended International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information is published 4 times a year.
Drug use and road safety - World Health Organization (WHO)
The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours.
Medicines - World Health Organization (WHO)
The first is regulatory issues, which can affect how medicines are bought to market, create lag times and cause the supply of medicines in some areas of the globe to be delayed long after they are available elsewhere. High prices, misuse of drugs and poor or unreliable drug quality contribute to this issue.
UN Commission approves WHO recommendations to place …
2025年3月13日 · The recommendations were developed by WHO Expert Committee on Drug Dependence--ECDD, which consists of global experts analyzing health risks and benefits of psychoactive substances circulating on global markets and alerting to include them under international control if evidence found that their use can cause harm for population health in ...
WHO promotes global drug safety through its Programme for International Drug Monitoring (PIDM), which began in the 1960s. Through the cooperative effort, Member States and WHO work together to identify possible relationships between the use of a drug and adverse effects. Countries that are members in the WHO PIDM are supported
Improving prevention and treatment for drug use disorders
The use of psychoactive drugs and psychotropic substances without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Untreated drug use disorders increase risks of morbidity and mortality for individuals, trigger substantial costs to society including lost productivity, increased health care expenditure, and …
WHO updates guidelines on opioid dependence treatment and …
Out of 600,000 deaths attributed to drug use, about 450 000 are due to use of opioids according to the latest WHO estimates. It is crucial that people with opioid dependence and those at risk of opioid overdose have access to prevention, harm reduction, treatment, and care, which are of good quality, affordable, ethical and evidence based.
WHO updates list of drug-resistant bacteria most threatening to …
2024年5月17日 · “By mapping the global burden of drug-resistant bacteria and assessing their impact on public health, this list is key to guiding investment and grappling with the antibiotics pipeline and access crisis," said Dr Yukiko Nakatani, WHO’s Assistant Director-General for Antimicrobial Resistance ad interim. “Since the first Bacterial Priority ...
Lexicon of alcohol and drug terms - World Health Organization …
1994年11月3日 · This term and its equivalent, psychotropic drug, are the most neutral and descriptive term for the whole class of substances, licit and illicit, of interest to drug policy. ‘Psychoactive’ does not necessarily imply dependence-producing, and in common parlance, the term is often left unstated, as in ‘drug use’ or ‘substance abuse’.